568 Pfizer made $19 Billion in Q2 this year, or $211 million per day. Some known risks of their jab are blood clots and cardiomyopathy. Luckily for them they make Eliquis for treating blood clots – sales up 13%. They also make Vyndaqel to treat cardiomyopathy – sales are up 77%! (twitter.com) posted 3 years ago by Vidura 3 years ago by Vidura +568 / -0 37 comments share 37 comments share save hide report block hide replies
2017
Trump to pharma: You're 'getting away with murder,' and I'm the one to stop it
Better do something quick, by round 4 of boosters we're gonna be missing half the population.
isn't that the goal .../?
Or, at very least, they will be disabled for life, removed from the workforce and require lifelong, ongoing medical care.
Hence the boosters? Can't have that kind of drain on (high) society